Smad2 and Smad4 gene mutations in hepatocellular carcinoma

被引：0
|
作者：
M C Yakicier
M B Irmak
A Romano
M Kew
M Ozturk
机构：
[1] Bilkent University,Department of Molecular Biology and Genetics
[2] University of The Witwatersrand,undefined
[3] Institute of Molecular Pathology,undefined
来源：
Oncogene | 1999年 / 18卷
关键词：
hepatocellular carcinoma; Smad2; Smad4; TGFβ; tumor suppressor genes; somatic mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
TGF-β is a negative regulator of liver growth. Smad family of genes, as mediators of TGF-β pathway, are candidate tumor suppressor genes in hepatocellular carcinoma (HCC). We studied 35 HCC and non-tumour liver tissues for possible mutations in Smad2 and Smad4 genes. Three tumours displayed somatic mutations; two in Smad4 (Asp332Gly and Cys401Arg) and one in Smad2 (Gln407Arg) genes. All three mutations were A:T → G:C transitions suspected to result from oxidative stress as observed in mitochondrial DNA. These observation demonstrate that TGF-β pathway is altered in hepatocellular carcinoma.
引用
下载
收藏
页码：4879 / 4883
页数：4
相关论文
共 50 条
  • [21] SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4
    Bertrand-Chapel, Adrien
    Caligaris, Cassandre
    Fenouil, Tanguy
    Savary, Clara
    Aires, Sophie
    Martel, Sylvie
    Huchede, Paul
    Chassot, Christelle
    Chauvet, Veronique
    Cardot-Ruffino, Victoire
    Morel, Anne-Pierre
    Subtil, Fabien
    Mohkam, Kayvan
    Mabrut, Jean-Yves
    Tonon, Laurie
    Viari, Alain
    Cassier, Philippe
    Hervieu, Valerie
    Castets, Marie
    Mauviel, Alain
    Sentis, Stephanie
    Bartholin, Laurent
    COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [22] SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4
    Adrien Bertrand-Chapel
    Cassandre Caligaris
    Tanguy Fenouil
    Clara Savary
    Sophie Aires
    Sylvie Martel
    Paul Huchedé
    Christelle Chassot
    Véronique Chauvet
    Victoire Cardot-Ruffino
    Anne-Pierre Morel
    Fabien Subtil
    Kayvan Mohkam
    Jean-Yves Mabrut
    Laurie Tonon
    Alain Viari
    Philippe Cassier
    Valérie Hervieu
    Marie Castets
    Alain Mauviel
    Stéphanie Sentis
    Laurent Bartholin
    Communications Biology, 5
  • [23] Smad2和Smad4蛋白与子宫内膜腺癌
    戴芙蓉
    张怡
    文继舫
    国际妇产科学杂志, 2006, (02) : 127 - 129
  • [24] Mutation analysis of transforming growth factor beta type I receptor, type II receptor, Smad2, Smad4, Smad6 and Smad7 in hepatocellular carcinoma.
    Kawate, S
    Ohwada, S
    Kunihiro, H
    Koyama, T
    Sakamoto, I
    Yoshinari, D
    Kasahara, M
    Tomizawa, N
    Kawashima, Y
    Takeyoshi, I
    Morishita, Y
    GASTROENTEROLOGY, 2000, 118 (04) : A1456 - A1456
  • [25] Abrogation of Smad3 and Smad2 or of Smad4 gene expression positively regulates murine embryonic lung branching morphogenesis in culture
    Zhao, JS
    Lee, M
    Smith, S
    Warburton, D
    DEVELOPMENTAL BIOLOGY, 1998, 194 (02) : 182 - 195
  • [26] Mutations of the Smad2 and Smad4 genes in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats
    Tsujiuchi, T
    Sasaki, Y
    Tsutsumi, M
    Konishi, Y
    MOLECULAR CARCINOGENESIS, 2000, 29 (02) : 87 - 91
  • [27] Smad2和Smad4蛋白在成年大鼠睾丸的表达
    胡静
    张远强
    王红
    张金山
    许若军
    解剖学报, 2001, (04) : 354 - 356
  • [28] Smad4 Expression in Hepatocellular Carcinoma Differs by Hepatitis Status
    Yao, Lei
    Li, Fu-Jun
    Tang, Zhi-Qiang
    Gao, Shuang
    Wu, De-Quan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (04) : 1297 - 1303
  • [29] Immunolocalisation and expression of Smad2 and Smad4 proteins in dog testis during postnatal development
    Zhang, X-J
    He, J-P
    Wen, X-X
    Zhao, L.
    ANDROLOGIA, 2011, 43 (04) : 254 - 260
  • [30] Abrogation of Smad3 and Smad2 or Smad4 positively regulates murine embryonic morphogenesis in culture.
    Zhao, JS
    Warburton, D
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 1410 - 1410
12345